Table 5 Achievement of LDL treatment target (LDL < 2.5 mmol/l) by the changes in use of lipid lowering medication
Changes in the use of lipid lowering medication | Overall achievement of treatment target | |||
|---|---|---|---|---|
Intensification of medication | No change in medication | De-intensification of medication | ||
Patient categories a | ||||
T2D only | (n = 500) | (n = 2264) | (n = 137) | (n = 2901) |
Proportion of patients undergoing changes in lipid medication, % | 17.2 | 78.0 | 4.7 | |
Target met 2011-12, % | 30.4 | 52.7 | 30.7 | 47.8 |
Target met 2015-16, % | 62.0 | 57.4 | 19.7 | 56.4 |
Change in achievement of treatment target (%) | 31.6 | 4.7 | -11.0 | 8.6 |
T2D + CVD | (n = 295) | (n = 1458) | (n = 92) | (n = 1845) |
Proportion of patients undergoing changes in lipid medication, % | 16.0 | 79.0 | 5.0 | |
Target met 2011-12, % | 49.5 | 70.1 | 48.9 | 65.7 |
Target met 2015-16, % | 71.9 | 73.7 | 39.1 | 71.7 |
Change in achievement of treatment target (%) | 22.4 | 3.6 | -9.8 | 6 |
T2D + AMD | (n = 86) | (n = 495) | (n = 27) | (n = 608) |
Proportion of patients undergoing changes in lipid medication, % | 14.1 | 81.4 | 4.4 | |
Target met 2011-12, % | 16.3 | 53.3 | 44.4 | 47.7 |
Target met 2015-16, % | 57.0 | 58.2 | 14.8 | 56.1 |
Change in achievement of treatment target (%) | 40.7 | 4.9 | -29.6 | 8.4 |
T2D + CVD + AMD | (n = 46) | (n = 248) | (n = 16) | (n = 310) |
Proportion of patients undergoing changes in lipid medication, % | 14.8 | 80.0 | 5.2 | |
Target met 2011-12, % | 34.8 | 67.7 | 43.8 | 61.6 |
Target met 2015-16, % | 67.4 | 70.6 | 18.8 | 67.4 |
Change in achievement of treatment target (%) | 32.6 | 2.9 | -25.0 | 5.8 |
P-value b | 0.043 | 0.983 | 0.318 | 0.731 |